Cargando...
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
BACKGROUND: In many clinical trials designed to assess the efficacy of anticancer treatments, overall survival (OS) is often used as a primary endpoint despite its several points of weakness. METHODS: This study evaluated the role of progression-free survival (PFS) in the first three lines of treatm...
Guardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5975605/ https://ncbi.nlm.nih.gov/pubmed/29872317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S151276 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|